Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological, and Molecular Features

Background: Pseudoprogression (PsP) mimics true early progression (TeP) in conventional imaging, which poses a diagnostic challenge in glioblastoma (GBM) patients who undergo standard concurrent chemoradiation (CCRT). This study aimed to investigate whether perioperative markers could distinguish an...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mingxiao, Ren, Xiaohui, Dong, Gehong, Wang, Jincheng, Jiang, Haihui, Yang, Chuanwei, Zhao, Xuzhe, Zhu, Qinghui, Cui, Yong, Yu, Kefu, Lin, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093388/
https://www.ncbi.nlm.nih.gov/pubmed/33959496
http://dx.doi.org/10.3389/fonc.2021.627325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093388/
https://www.ncbi.nlm.nih.gov/pubmed/33959496
http://dx.doi.org/10.3389/fonc.2021.627325

Ejemplares similares